Abstract:Adipocyte differentiation is thought to involve sequential induction of the transcription factors C/EBP, peroxisome proliferator-activated receptor ␥ (PPAR␥), and C/EBP␣. C/EBP␣ expression is both necessary and sufficient for adipocyte differentiation. Here we report that ectopic expression of either C/EBP␣ or C/EBP induces PPAR␥ expression and adipogenesis and that retinoic acid (RA) completely inhibits adipogenesis by either form of C/EBP. In studies of normal preadipocytes, RA does not prevent C/EBP indu… Show more
“…For experiments involving RA, retrovirally infected cells were studied in the following two protocols: 1) cells were maintained in the constant presence of 10 M RA from the time of infection and then exposed to the presence or absence of 1 M BRL49653 at day 0, or 2) cells were grown in the absence of RA until day 0 and then exposed to RA and various conditions. The first of these two conditions corresponds to that described previously (13).…”
Section: Methodsmentioning
confidence: 99%
“…Indeed, during normal 3T3-L1 differentiation, RA loses effectiveness at times when PPAR␥ and C/EBP␣ are simultaneously expressed in the cells (23). Since C/EBP␣ (13) and C/EBP induce PPAR␥ (12, 13), we considered the possibility that PPAR␥ and C/EBP␣ may induce each other, leading after some time to a state that is refractory to RA inhibition of adipogenesis. To determine whether PPAR␥ is able to activate C/EBP␣ gene expression, L1-PPAR␥ cells were collected prior to differentiation and subjected to Western analysis.…”
Section: Ra Inhibits Ppar␥ Ligand-mediated Adipogenesis In 3t3 L1mentioning
confidence: 99%
“…Liganded RAR blocks C/EBPstimulated gene transcription, and RA also prevents adipogenesis due to ectopic expression of C/EBP␣ or - (13). However, during normal adipogenesis RA exerts its inhibitory function only when added in the first 24 -48 h after exposure to differentiating stimuli that are applied postconfluence.…”
mentioning
confidence: 99%
“…7). Enforced expression of PPAR␥ (8), C/EBP␣ (9 -11), or C/EBP (10,12,13) stimulates adipogenesis in NIH 3T3 fibroblasts, suggesting the essential roles of these transcription factors in regulating adipogenesis. Furthermore, combined expression of PPAR␥ and C/EBP␣ has synergistic effects on promoting fat cell conversion in myoblasts (14).…”
Terminal differentiation of stem cells is characterized by cessation of cell proliferation as well as changes in cell morphology associated with the differentiated state. For adipocyte differentiation, independent lines of evidence show that the transcription factors peroxisome proliferator activated receptor ␥ (PPAR␥) and CCAAT/ enhancer-binding protein ␣ (C/EBP␣) as well as the tumor suppressor retinoblastoma (Rb) protein are essential. How these proteins promote adipocyte conversion and how they function cooperatively during the differentiation process remain unclear. We have used retinoic acid (RA) inhibition of adipogenesis to investigate these issues. RA blocked adipogenesis of 3T3-L1 cells induced to differentiate by ectopic expression of PPAR␥ and C/EBP␣ independently or together. However, under these circumstances RA was only effective at preventing adipogenesis when added prior to confluence, suggesting that factors involved in regulation of the cell cycle might play a role in establishing the commitment state of adipogenesis that is insensitive to RA. During differentiation of wild type 3T3 L1 preadipocytes, we found that Rb protein is hyperphosphorylated early in adipogenesis, corresponding to previously quiescent cells reentering the cell cycle, and later becomes hypophosphorylated. The data suggest that, together with the coexpression of PPAR␥ and C/EBP␣, permanent exit from the cell cycle establishes the irreversible commitment to adipocyte differentiation.
“…For experiments involving RA, retrovirally infected cells were studied in the following two protocols: 1) cells were maintained in the constant presence of 10 M RA from the time of infection and then exposed to the presence or absence of 1 M BRL49653 at day 0, or 2) cells were grown in the absence of RA until day 0 and then exposed to RA and various conditions. The first of these two conditions corresponds to that described previously (13).…”
Section: Methodsmentioning
confidence: 99%
“…Indeed, during normal 3T3-L1 differentiation, RA loses effectiveness at times when PPAR␥ and C/EBP␣ are simultaneously expressed in the cells (23). Since C/EBP␣ (13) and C/EBP induce PPAR␥ (12, 13), we considered the possibility that PPAR␥ and C/EBP␣ may induce each other, leading after some time to a state that is refractory to RA inhibition of adipogenesis. To determine whether PPAR␥ is able to activate C/EBP␣ gene expression, L1-PPAR␥ cells were collected prior to differentiation and subjected to Western analysis.…”
Section: Ra Inhibits Ppar␥ Ligand-mediated Adipogenesis In 3t3 L1mentioning
confidence: 99%
“…Liganded RAR blocks C/EBPstimulated gene transcription, and RA also prevents adipogenesis due to ectopic expression of C/EBP␣ or - (13). However, during normal adipogenesis RA exerts its inhibitory function only when added in the first 24 -48 h after exposure to differentiating stimuli that are applied postconfluence.…”
mentioning
confidence: 99%
“…7). Enforced expression of PPAR␥ (8), C/EBP␣ (9 -11), or C/EBP (10,12,13) stimulates adipogenesis in NIH 3T3 fibroblasts, suggesting the essential roles of these transcription factors in regulating adipogenesis. Furthermore, combined expression of PPAR␥ and C/EBP␣ has synergistic effects on promoting fat cell conversion in myoblasts (14).…”
Terminal differentiation of stem cells is characterized by cessation of cell proliferation as well as changes in cell morphology associated with the differentiated state. For adipocyte differentiation, independent lines of evidence show that the transcription factors peroxisome proliferator activated receptor ␥ (PPAR␥) and CCAAT/ enhancer-binding protein ␣ (C/EBP␣) as well as the tumor suppressor retinoblastoma (Rb) protein are essential. How these proteins promote adipocyte conversion and how they function cooperatively during the differentiation process remain unclear. We have used retinoic acid (RA) inhibition of adipogenesis to investigate these issues. RA blocked adipogenesis of 3T3-L1 cells induced to differentiate by ectopic expression of PPAR␥ and C/EBP␣ independently or together. However, under these circumstances RA was only effective at preventing adipogenesis when added prior to confluence, suggesting that factors involved in regulation of the cell cycle might play a role in establishing the commitment state of adipogenesis that is insensitive to RA. During differentiation of wild type 3T3 L1 preadipocytes, we found that Rb protein is hyperphosphorylated early in adipogenesis, corresponding to previously quiescent cells reentering the cell cycle, and later becomes hypophosphorylated. The data suggest that, together with the coexpression of PPAR␥ and C/EBP␣, permanent exit from the cell cycle establishes the irreversible commitment to adipocyte differentiation.
“…11 Once PPARg2 and C/EBPa have been activated, 'cross-talk' between PPARg2 and C/EBPa maintains the expression of each protein during adipocyte differentiation, even in the absence of C/EBPb and C/EBPd. 12,13 Jun dimerization protein 2 (JDP2) is a DNA-binding protein that forms homodimers or heterodimers with c-Jun, ATF2 and C/EBPg. [14][15][16] JDP2 can function not only as a transcriptional repressor but also as a coactivator in various types of cell, 15,[17][18][19][20] and it is involved in a variety of biological phenomena such as proliferation and differentiation of cells and apoptosis.…”
Among the events that control cellular differentiation, the acetylation of histones plays a critical role in the regulation of transcription and the modification of chromatin. Jun dimerization protein 2 (JDP2), a member of the AP-1 family, is an inhibitor of such acetylation and contributes to the maintenance of chromatin structure. In an examination of Jdp2 'knock-out' (KO) mice, we observed elevated numbers of white adipocytes and significant accumulation of lipid in the adipose tissue in sections of scapulae. In addition, mouse embryo fibroblasts (MEFs) from Jdp2 KO mice were more susceptible to adipocyte differentiation in response to hormonal induction and members of the CCAAT/enhancer-binding proteins (C/EBP) gene family were expressed at levels higher than MEFs from wild-type mice. Furthermore, JDP2 inhibited both the acetylation of histone H3 in the promoter of the gene for C/EBPd and transcription from this promoter. Our data indicate that JDP2 plays a key role as a repressor of adipocyte differentiation by regulating the expression of the gene for C/EBPd via inhibition of histone acetylation.
The adipocyte is now known to play an active role in many physiological and pathological processes regarding energy metabolism. Consideration of adipose tissue as an endocrine organ that secretes a variety of unrelated bioactive molecules has broadened our appreciation of adipocyte function to exceed the once considered passive role in lipid metabolism. Growing interest in this tissue has lead to significant advances regarding the molecular basis for adipocyte differentiation. Several diverse families of transcription factors are currently under active investigation for their roles in mediating this complex process. Knowledge concerning the sequence of transcriptional events during adipogenesis and the interplay among adipogenic transcription factors provides a basis for understanding the physiological processes associated with adipose tissue as well as for the development of therapeutic intervention of adipocyte related diseases.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.